{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:16:43Z","timestamp":1781291803317,"version":"3.54.1"},"reference-count":37,"publisher":"Baskent University","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.6002\/ect.2018.0296","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T10:43:59Z","timestamp":1557139439000},"page":"284-291","source":"Crossref","is-referenced-by-count":3,"title":["Alemtuzumab Induction Is Associated With Equalization of Graft Outcomes Between Elderly and Nonelderly Kidney Transplant Recipients: A Single-Center Report"],"prefix":"10.6002","volume":"18","author":[{"given":"Anthony","family":"DeLeonibus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Mitro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4021","reference":[{"key":"ref0","unstructured":"1. United Network for Organ Sharing U. Transplant Trends. 2017; https:\/\/unos.org\/data\/transplant-trends\/."},{"key":"ref1","unstructured":"2. Shetty A, Friedewald JJ. Kidney transplantation in the elderly. ASN Kidney News. 2015;7(8):3."},{"issue":"3","key":"ref2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/ctr.12507","article-title":"Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients","volume":"29","author":"Palanisamy","year":"2015","unstructured":"3. Palanisamy AP, Al Manasra AR, Pilch NA, et al. Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients. Clin Transplant. 2015;29(3):222-226.","journal-title":"Clin Transplant"},{"issue":"6","key":"ref3","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000334092","article-title":"Poor outcomes in elderly kidney transplant recipients receiving alemtuzumab induction","volume":"34","author":"Hurst","year":"2011","unstructured":"4. Hurst FP, Altieri M, Nee R, Agodoa LY, Abbott KC, Jindal RM. Poor outcomes in elderly kidney transplant recipients receiving alemtuzumab induction. Am J Nephrol. 2011;34(6):534-541.","journal-title":"Am J Nephrol"},{"issue":"5","key":"ref4","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.2215\/CJN.07540810","article-title":"Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States","volume":"6","author":"Gill","year":"2011","unstructured":"5. Gill J, Sampaio M, Gill JS, et al. Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States. Clin J Am Soc Nephrol. 2011;6(5):1168-1178.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"14","key":"ref5","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1056\/NEJMc1103007","article-title":"Kidney allocation and the aging immune response","volume":"364","author":"SG","year":"2011","unstructured":"6. Tullius SG, Milford E. Kidney allocation and the aging immune response. N Engl J Med. 2011;364(14):1369-1370.","journal-title":"N Engl J Med"},{"issue":"2","key":"ref6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/00007890-200007270-00012","article-title":"Relationship of recipient age and development of chronic allograft failure","volume":"70","author":"Meier-Kriesche","year":"2000","unstructured":"7. Meier-Kriesche HU, Ojo AO, Cibrik DM, et al. Relationship of recipient age and development of chronic allograft failure. Transplantation. 2000;70(2):306-310.","journal-title":"Transplantation"},{"issue":"20","key":"ref7","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1056\/NEJMe1103002","article-title":"Alemtuzumab in kidney-transplant recipients","volume":"364","author":"JF","year":"2011","unstructured":"8. Markmann JF, Fishman JA. Alemtuzumab in kidney-transplant recipients. N Engl J Med. 2011;364(20):1968-1969.","journal-title":"N Engl J Med"},{"issue":"19","key":"ref8","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","unstructured":"9. Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D, Thymoglobulin Induction Study Group. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med. 2006;355(19):1967-1977.","journal-title":"N Engl J Med"},{"issue":"3","key":"ref9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.6002\/ect.2012.0211","article-title":"Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients","volume":"11","author":"Khanmoradi","year":"2013","unstructured":"10. Khanmoradi K, Knorr JP, Feyssa EL, et al. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients. Exp Clin Transplant. 2013;11(3):222-228.","journal-title":"Exp Clin Transplant"},{"issue":"10","key":"ref10","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1097\/TP.0b013e3181a4b67d","article-title":"Deceased-donor renal transplantation in the geriatric population demonstrates equal graft survival compared with younger recipients","volume":"87","author":"Sener","year":"2009","unstructured":"11. Sener A, Schweitzer EJ, Munivenkatappa R, et al. Deceased-donor renal transplantation in the geriatric population demonstrates equal graft survival compared with younger recipients. Transplantation. 2009;87(10):1549-1554.","journal-title":"Transplantation"},{"issue":"8","key":"ref11","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/01.tp.0000259621.56861.31","article-title":"Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients","volume":"83","author":"Rao","year":"2007","unstructured":"12. Rao PS, Merion RM, Ashby VB, Port FK, Wolfe RA, Kayler LK. Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation. 2007;83(8):1069-1074.","journal-title":"Transplantation"},{"issue":"23","key":"ref12","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","unstructured":"13. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725-1730.","journal-title":"N Engl J Med"},{"issue":"1","key":"ref13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.transproceed.2007.11.028","article-title":"Renal transplantation in elderly recipients: a single-center experience","volume":"40","author":"Ghafari","year":"2008","unstructured":"14. Ghafari A, Ardalan MR. Renal transplantation in elderly recipients: a single-center experience. Transplant Proc. 2008;40(1):238-239.","journal-title":"Transplant Proc"},{"issue":"3","key":"ref14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2215\/CJN.01130905","article-title":"Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis","volume":"1","author":"Schold","year":"2006","unstructured":"15. Schold JD, Meier-Kriesche HU. Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis? Clin J Am Soc Nephrol. 2006;1(3):532-538.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"ref15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s11255-004-0010-6","article-title":"Live and deceased donor kidney transplantation in patients aged 75 years and older in the United States","volume":"37","author":"Macrae","year":"2005","unstructured":"16. Macrae J, Friedman AL, Friedman EA, Eggers P. Live and deceased donor kidney transplantation in patients aged 75 years and older in the United States. Int Urol Nephrol. 2005;37(3):641-648.","journal-title":"Int Urol Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Danovitch G, Savransky E. Challenges in the counseling and management of older kidney transplant candidates. Am J Kidney Dis. 2006;47(4 Suppl 2):S86-97.","DOI":"10.1053\/j.ajkd.2005.12.042"},{"issue":"7","key":"ref17","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/ctr.12756","article-title":"Prognostic factors in kidney transplantation in the septuagenarian: a multicenter analysis","volume":"30","author":"Saucedo-Crespo","year":"2016","unstructured":"18. Saucedo-Crespo H, Haakinson DJ, Croome KP, et al. Prognostic factors in kidney transplantation in the septuagenarian: a multicenter analysis. Clin Transplant. 2016;30(7):828-835.","journal-title":"Clin Transplant"},{"issue":"12","key":"ref18","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1097\/TP.0000000000001363","article-title":"Are octogenarians with end-stage renal disease candidates for renal transplantation","volume":"100","author":"Lonning","year":"2016","unstructured":"19. Lonning K, Midtvedt K, Leivestad T, et al. Are octogenarians with end-stage renal disease candidates for renal transplantation? Transplantation. 2016;100(12):2705-2709.","journal-title":"Transplantation"},{"issue":"10","key":"ref19","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1097\/TP.0000000000001002","article-title":"Survival benefit in renal transplantation despite high comorbidity","volume":"100","author":"Sorensen","year":"2016","unstructured":"20. Sorensen VR, Heaf J, Wehberg S, Sorensen SS. Survival benefit in renal transplantation despite high comorbidity. Transplantation. 2016;100(10):2160-2167.","journal-title":"Transplantation"},{"issue":"5","key":"ref20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1399-0012.2010.01343.x","article-title":"The relative risk of overall graft loss and acute rejection among African American renal transplant recipients is attenuated with advancing age","volume":"25","author":"Schold","year":"2011","unstructured":"21. Schold JD, Srinivas TR, Braun WE, Shoskes DA, Nurko S, Poggio ED. The relative risk of overall graft loss and acute rejection among African American renal transplant recipients is attenuated with advancing age. Clin Transplant. 2011;25(5):721-730.","journal-title":"Clin Transplant"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Brooks JT, Mitro G, DeLeonibus A, et al. Alemtuzumab induction is associated with an equalization of outcomes between White and African American kidney transplant recipients. Exp Clin Transplant. In press. doi: 10.6002\/ect.2017.0065.","DOI":"10.6002\/ect.2017.0065"},{"issue":"2","key":"ref22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2215\/CJN.00630805","article-title":"Role of socioeconomic status in kidney transplant outcome","volume":"1","author":"Goldfarb-Rumyantzev","year":"2006","unstructured":"23. Goldfarb-Rumyantzev AS, Koford JK, Baird BC, et al. Role of socioeconomic status in kidney transplant outcome. Clin J Am Soc Nephrol. 2006;1(2):313-322.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"ref23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.semnephrol.2009.10.009","article-title":"Disparities in kidney transplant outcomes: a review","volume":"30","author":"Gordon","year":"2010","unstructured":"24. Gordon EJ, Ladner DP, Caicedo JC, Franklin J. Disparities in kidney transplant outcomes: a review. Semin Nephrol. 2010;30(1):81-89.","journal-title":"Semin Nephrol"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Patel N, Weimert NA. High-risk recipients in kidney transplantation. In: Veroux M (ed.). Kidney Transplantation: Challenging the Future. Sharjah, UAE: Bentham Science Publishers; 2012:20.","DOI":"10.2174\/978160805144111201010027"},{"issue":"3","key":"ref25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.tp.0000275423.69689.dc","article-title":"Immunosuppression of the elderly kidney transplant recipient","volume":"84","author":"Danovitch","year":"2007","unstructured":"26. Danovitch GM, Gill J, Bunnapradist S. Immunosuppression of the elderly kidney transplant recipient. Transplantation. 2007;84(3):285-291.","journal-title":"Transplantation"},{"issue":"1","key":"ref26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00415-005-0934-5","article-title":"The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy","volume":"253","author":"Coles","year":"2006","unstructured":"27. Coles AJ, Cox A, Le Page E, et al. The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. J Neurol. 2006;253(1):98-108.","journal-title":"J Neurol"},{"issue":"12","key":"ref27","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.4049\/jimmunol.1301926","article-title":"Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis","volume":"191","author":"Zhang","year":"2013","unstructured":"28. Zhang X, Tao Y, Chopra M, et al. Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis. J Immunol. 2013;191(12):5867-5874.","journal-title":"J Immunol"},{"issue":"8","key":"ref28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.molmed.2010.06.002","article-title":"Neutrophils: game changers in glomerulonephritis","volume":"16","author":"Mayadas","year":"2010","unstructured":"29. Mayadas TN, Rosetti F, Ernandez T, Sethi S. Neutrophils: game changers in glomerulonephritis? Trends Mol Med. 2010;16(8):368-378.","journal-title":"Trends Mol Med"},{"issue":"14","key":"ref29","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1182\/blood-2009-02-203075","article-title":"Neutrophils express CD52 and exhibit complement-mediated lysis in the presence of alemtuzumab","volume":"114","author":"Ambrose","year":"2009","unstructured":"30. Ambrose LR, Morel AS, Warrens AN. Neutrophils express CD52 and exhibit complement-mediated lysis in the presence of alemtuzumab. Blood. 2009;114(14):3052-3055.","journal-title":"Blood"},{"issue":"7","key":"ref30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/01.tp.0000281942.97406.89","article-title":"Alemtuzumab induction in deceased donor kidney transplantation","volume":"84","author":"Huang","year":"2007","unstructured":"31. Huang E, Cho YW, Hayashi R, Bunnapradist S. Alemtuzumab induction in deceased donor kidney transplantation. Transplantation. 2007;84(7):821-828.","journal-title":"Transplantation"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Neri F, Furian L, Cavallin F, et al. How does age affect the outcome of kidney transplantation in elderly recipients? Clin Transplant. 2017;31(10).","DOI":"10.1111\/ctr.13036"},{"issue":"3","key":"ref32","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.transproceed.2016.02.039","article-title":"Immunosuppressive therapy for elderly kidney transplant recipients","volume":"48","author":"Iwamoto","year":"2016","unstructured":"33. Iwamoto H, Nakamura Y, Konno O, et al. Immunosuppressive therapy for elderly kidney transplant recipients. Transplant Proc. 2016;48(3):799-801.","journal-title":"Transplant Proc"},{"issue":"11","key":"ref33","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1097\/00007890-199706150-00015","article-title":"European Multicenter Study Group","volume":"63","author":"Koning","year":"1997","unstructured":"34. Koning OH, Ploeg RJ, van Bockel JH, et al. Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation. 1997;63(11):1620-1628.","journal-title":"Transplantation"},{"issue":"7","key":"ref34","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/TP.0b013e31819cdddd","article-title":"Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity","volume":"87","author":"Heldal","year":"2009","unstructured":"35. Heldal K, Hartmann A, Leivestad T, et al. Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity. Transplantation. 2009;87(7):1045-1051.","journal-title":"Transplantation"},{"issue":"3","key":"ref35","doi-asserted-by":"publisher","first-page":"232","DOI":"10.6002\/ect.2011.0137","article-title":"Early allograft biopsies performed during delayed graft function may not be necessary under thymoglobulin induction","volume":"10","author":"Ortiz","year":"2012","unstructured":"36. Ortiz J, Parsikia A, Mumtaz K, et al. Early allograft biopsies performed during delayed graft function may not be necessary under thymoglobulin induction. Exp Clin Transplant. 2012;10(3):232-238.","journal-title":"Exp Clin Transplant"},{"issue":"4","key":"ref36","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/ndt\/gfh022","article-title":"How great is the survival advantage of transplantation over dialysis in elderly patients","volume":"19","author":"Oniscu","year":"2004","unstructured":"37. Oniscu GC, Brown H, Forsythe JL. How great is the survival advantage of transplantation over dialysis in elderly patients? Nephrol Dial Transplant. 2004;19(4):945-951.","journal-title":"Nephrol Dial Transplant"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T07:23:29Z","timestamp":1591773809000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2020\/18\/3\/0\/284\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2018.0296","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}